Efficiency along with protection regarding every week paclitaxel without or with ramucirumab since second-line treatment to treat sophisticated gastric or gastroesophageal 4 way stop adenocarcinoma (RAINBOW-Asia): the randomised, multicentre, double-blind, stage 3 tryout.